CATALOG PRODUCT FINDER
SEARCH BY KEYWORD:
SEARCH BY SCIENTIFIC FIELD:
SARS-CoV-2 Spike Products
Select your SARS-CoV-2 Spike products including PepMix™ Peptide Pools, RepliTope™ Peptide Microarrays and Antigen Peptides!
PepMix™ Peptide Pools
EMPS-229E-S-1
Epitope Mapping Peptide Set HCoV-229E (Spike Glycoprotein)
Set of 50 Matrix Pools and 291 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus 229E (HCoV-229E) for epitope identification and mapping
Set of 50 Matrix Pools and 291 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus 229E (HCoV-229E) for epitope identification and mapping

Epitope Mapping Peptide Set HCoV-229E (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | Human coronavirus (HCoV) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 291 |
Further Information:
Amount | 50 Matrix pools and 291 individual peptide aliquots (5 µg each) |
Specifications | Peptide scan (optimized scan into 15 mers) |
Documentation | Protocol, Datasheet and Annotations |
Swiss-Prot ID | |
Sequence |
MFVLLVAYALLHIAGCQTTNGLNTSYSV CNGCVGYSENVFAVESGGYIPSDFAFNN WFLLTNTSSVVDGVVRSFQPLLLNCLWS VSGLRFTTGFVYFNGTGRGDCKGFSSDV LSDVIRYNLNFEENLRRGTILFKTSYGV VVFYCTNNTLVSGDAHIPFGTVLGNFYC FVNTTIGNETTSAFVGALPKTVREFVIS RTGHFYINGYRYFTLGNVEAVNFNVTTA ETTDFCTVALASYADVLVNVSQTSIANI IYCNSVINRLRCDQLSFDVPDGFYSTSP IQSVELPVSIVSLPVYHKHTFIVLYVDF KPQSGGGKCFNCYPAGVNITLANFNETK GPLCVDTSHFTTKYVAVYANVGRWSASI NTGNCPFSFGKVNNFVKFGSVCFSLKDI PGGCAMPIVANWAYSKYYTIGSLYVSWS DGDGITGVPQPVEGVSSFMNVTLDKCTK YNIYDVSGVGVIRVSNDTFLNGITYTST SGNLLGFKDVTKGTIYSITPCNPPDQLV VYQQAVVGAMLSENFTSYGFSNVVELPK FFYASNGTYNCTDAVLTYSSFGVCADGS IIAVQPRNVSYDSVSAIVTANLSIPSNW TTSVQVEYLQITSTPIVVDCSTYVCNGN VRCVELLKQYTSACKTIEDALRNSARLE SADVSEMLTFDKKAFTLANVSSFGDYNL SSVIPSLPTSGSRVAGRSAIEDILFSKL VTSGLGTVDADYKKCTKGLSIADLACAQ YYNGIMVLPGVADAERMAMYTGSLIGGI ALGGLTSAVSIPFSLAIQARLNYVALQT DVLQENQKILAASFNKAMTNIVDAFTGV NDAITQTSQALQTVATALNKIQDVVNQQ GNSLNHLTSQLRQNFQAISSSIQAIYDR LDTIQADQQVDRLITGRLAALNVFVSHT LTKYTEVRASRQLAQQKVNECVKSQSKR YGFCGNGTHIFSIVNAAPEGLVFLHTVL LPTQYKDVEAWSGLCVDGTNGYVLRQPN LALYKEGNYYRITSRIMFEPRIPTMADF VQIENCNVTFVNISRSELQTIVPEYIDV NKTLQELSYKLPNYTVPDLVVEQYNQTI LNLTSEISTLENKSAELNYTVQKLQTLI DNINSTLVDLKWLNRVETYIKWPWWVWL CISVVLIFVVSMLLLCCCSTGCCGFFSC FASSIRGCCESTKLPYYDVEKIHIQ |
Protein Length (aa) | 1173 |

EMPS-HKU1-S-1
Epitope Mapping Peptide Set HCoV-HKU1 (Spike Glycoprotein)
Set of 52 Matrix Pools and 337 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus HKU1 (HCoV-HKU1) for epitope identification and mapping
Set of 52 Matrix Pools and 337 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus HKU1 (HCoV-HKU1) for epitope identification and mapping

Epitope Mapping Peptide Set HCoV-HKU1 (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | Human coronavirus (HCoV) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 337 |
Further Information:
Amount | 52 Matrix pools and 337 individual peptide aliquots (5 µg each) |
Specifications | Peptide scan (optimized scan into 15 mers) |
Documentation | Protocol, Datasheet and Annotations |
Swiss-Prot ID | |
Sequence |
MLLIIFILPTTLAVIGDFNCTNFAINDL NTTVPRISEYVVDVSYGLGTYYILDRVY LNTTILFTGYFPKSGANFRDLSLKGTTY LSTLWYQKPFLSDFNNGIFSRVKNTKLY VNKTLYSEFSTIVIGSVFINNSYTIVVQ PHNGVLEITACQYTMCEYPHTICKSKGS SRNESWHFDKSEPLCLFKKNFTYNVSTD WLYFHFYQERGTFYAYYADSGMPTTFLF SLYLGTLLSHYYVLPLTCNAISSNTDNE TLQYWVTPLSKRQYLLKFDNRGVITNAV DCSSSFFSEIQCKTKSLLPNTGVYDLSG FTVKPVATVHRRIPDLPDCDIDKWLNNF NVPSPLNWERKIFSNCNFNLSTLLRLVH TDSFSCNNFDESKIYGSCFKSIVLDKFA IPNSRRSDLQLGSSGFLQSSNYKIDTTS SSCQLYYSLPAINVTINNYNPSSWNRRY GFNNFNLSSHSVVYSRYCFSVNNTFCPC AKPSFASSCKSHKPPSASCPIGTNYRSC ESTTVLDHTDWCRCSCLPDPITAYDPRS CSQKKSLVGVGEHCAGFGVDEEKCGVLD GSYNVSCLCSTDAFLGWSYDTCVSNNRC NIFSNFILNGINSGTTCSNDLLQPNTEV FTDVCVDYDLYGITGQGIFKEVSAVYYN SWQNLLYDSNGNIIGFKDFVTNKTYNIF PCYAGRVSAAFHQNASSLALLYRNLKCS YVLNNISLTTQPYFDSYLGCVFNADNLT DYSVSSCALRMGSGFCVDYNSPSSSSSR RKRRSISASYRFVTFEPFNVSFVNDSIE SVGGLYEIKIPTNFTIVGQEEFIQTNSP KVTIDCSLFVCSNYAACHDLLSEYGTFC DNINSILDEVNGLLDTTQLHVADTLMQG VTLSSNLNTNLHFDVDNINFKSLVGCLG PHCGSSSRSFFEDLLFDKVKLSDVGFVE AYNNCTGGSEIRDLLCVQSFNGIKVLPP ILSESQISGYTTAATVAAMFPPWSAAAG IPFSLNVQYRINGLGVTMDVLNKNQKLI ATAFNNALLSIQNGFSATNSALAKIQSV VNSNAQALNSLLQQLFNKFGAISSSLQE ILSRLDALEAQVQIDRLINGRLTALNAY VSQQLSDISLVKFGAALAMEKVNECVKS QSPRINFCGNGNHILSLVQNAPYGLLFM HFSYKPISFKTVLVSPGLCISGDVGIAP KQGYFIKHNDHWMFTGSSYYYPEPISDK NVVFMNTCSVNFTKAPLVYLNHSVPKLS DFESELSHWFKNQTSIAPNLTLNLHTIN ATFLDLYYEMNLIQESIKSLNNSYINLK DIGTYEMYVKWPWYVWLLISFSFIIFLV LLFFICCCTGCGSACFSKCHNCCDEYGG HHDFVIKTSHDD |
Protein Length (aa) | 1356 |

EMPS-NL63-S-1
Epitope Mapping Peptide Set HCoV-NL63 (Spike Glycoprotein)
Set of 52 Matrix Pools and 337 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus NL63 (HCoV-NL63) for epitope identification and mapping
Set of 52 Matrix Pools and 337 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus NL63 (HCoV-NL63) for epitope identification and mapping

Epitope Mapping Peptide Set HCoV-NL63 (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | Human coronavirus (HCoV) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 337 |
Further Information:
Amount | 52 Matrix pools and 337 individual peptide aliquots (5 µg each) |
Specifications | Peptide scan (optimized scan into 15 mers) |
Documentation | Protocol, Datasheet and Annotations |
Swiss-Prot ID | |
Sequence |
MKLFLILLVLPLASCFFTCNSNANLSML QLGVPDNSSTIVTGLLPTHWFCANQSTS VYSANGFFYIDVGNHRSAFALHTGYYDA NQYYIYVTNEIGLNASVTLKICKFSRNT TFDFLSNASSSFDCIVNLLFTEQLGAPL GITISGETVRLHLYNVTRTFYVPAAYKL TKLSVKCYFNYSCVFSVVNATVTVNVTT HNGRVVNYTVCDDCNGYTDNIFSVQQDG RIPNGFPFNNWFLLTNGSTLVDGVSRLY QPLRLTCLWPVPGLKSSTGFVYFNATGS DVNCNGYQHNSVVDVMRYNLNFSANSLD NLKSGVIVFKTLQYDVLFYCSNSSSGVL DTTIPFGPSSQPYYCFINSTINTTHVST FVGILPPTVREIVVARTGQFYINGFKYF DLGFIEAVNFNVTTASATDFWTVAFATF VDVLVNVSATNIQNLLYCDSPFEKLQCE HLQFGLQDGFYSANFLDDNVLPETYVAL PIYYQHTDINFTATASFGGSCYVCKPHQ VNISLNGNTSVCVRTSHFSIRYIYNRVK SGSPGDSSWHIYLKSGTCPFSFSKLNNF QKFKTICFSTVEVPGSCNFPLEATWHYT SYTIVGALYVTWSEGNSITGVPYPVSGI REFSNLVLNNCTKYNIYDYVGTGIIRSS NQSLAGGITYVSNSGNLLGFKNVSTGNI FIVTPCNQPDQVAVYQQSIIGAMTAVNE SRYGLQNLLQLPNFYYVSNGGNNCTTAV MTYSNFGICADGSLIPVRPRNSSDNGIS AIITANLSIPSNWTTSVQVEYLQITSTP IVVDCATYVCNGNPRCKNLLKQYTSACK TIEDALRLSAHLETNDVSSMLTFDSNAF SLANVTSFGDYNLSSVLPQRNIRSSRIA GRSALEDLLFSKVVTSGLGTVDVDYKSC TKGLSIADLACAQYYNGIMVLPGVADAE RMAMYTGSLIGGMVLGGLTSAAAIPFSL ALQARLNYVALQTDVLQENQKILAASFN KAINNIVASFSSVNDAITQTAEAIHTVT IALNKIQDVVNQQGSALNHLTSQLRHNF QAISNSIQAIYDRLDSIQADQQVDRLIT GRLAALNAFVSQVLNKYTEVRGSRRLAQ QKINECVKSQSNRYGFCGNGTHIFSIVN SAPDGLLFLHTVLLPTDYKNVKAWSGIC VDGIYGYVLRQPNLVLYSDNGVFRVTSR VMFQPRLPVLSDFVQIYNCNVTFVNISR VELHTVIPDYVDVNKTLQEFAQNLPKYV KPNFDLTPFNLTYLNLSSELKQLEAKTA SLFQTTVELQGLIDQINSTYVDLKLLNR FENYIKWPWWVWLIISVVFVVLLSLLVF CCLSTGCCGCCNCLTSSMRGCCDCGSTK LPYYEFEKVHVQ |
Protein Length (aa) | 1356 |

EMPS-OC43-S-1
Epitope Mapping Peptide Set HCoV-OC43 (Spike Glycoprotein)
Set of 52 Matrix Pools and 336 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus OC43 (HCoV-OC43) for epitope identification and mapping
Set of 52 Matrix Pools and 336 individual overlapping peptides spanning the whole Spike glycoprotein of Human coronavirus OC43 (HCoV-OC43) for epitope identification and mapping

Epitope Mapping Peptide Set HCoV-OC43 (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | Human coronavirus (HCoV) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 336 |
Further Information:
Amount | 52 Matrix pools and 336 individual peptide aliquots (5 µg each) |
Specifications | Peptide scan (optimized scan into 15 mers) |
Documentation | Protocol, Datasheet and Annotations |
Swiss-Prot ID | |
Sequence |
MFLILLISLPTAFAVIGDLKCTSDNIND KDTGPPPISTDTVDVTNGLGTYYVLDRV YLNTTLFLNGYYPTSGSTYRNMALKGSV LLSRLWFKPPFLSDFINGIFAKVKNTKV IKDRVMYSEFPAITIGSTFVNTSYSVVV QPRTINSTQDGDNKLQGLLEVSVCQYNM CEYPQTICHPNLGNHRKELWHLDTGVVS CLYKRNFTYDVNADYLYFHFYQEGGTFY AYFTDTGVVTKFLFNVYLGMALSHYYVM PLTCNSKLTLEYWVTPLTSRQYLLAFNQ DGIIFNAEDCMSDFMSEIKCKTQSIAPP TGVYELNGYTVQPIADVYRRKPNLPNCN IEAWLNDKSVPSPLNWERKTFSNCNFNM SSLMSFIQADSFTCNNIDAAKIYGMCFS SITIDKFAIPNGRKVDLQLGNLGYLQSF NYRIDTTATSCQLYYNLPAANVSVSRFN PSTWNKRFGFIEDSVFKPRPAGVLTNHD VVYAQHCFKAPKNFCPCKLNGSCVGSGP GKNNGIGTCPAGTNYLTCDNLCTPDPIT FTGTYKCPQTKSLVGIGEHCSGLAVKSD YCGGNSCTCRPQAFLGWSADSCLQGDKC NIFANFILHDVNSGLTCSTDLQKANTDI ILGVCVNYDLYGILGQGIFVEVNATYYN SWQNLLYDSNGNLYGFRDYIINRTFMIR SCYSGRVSAAFHANSSEPALLFRNIKCN YVFNNSLTRQLQPINYFDSYLGCVVNAY NSTAISVQTCDLTVGSGYCVDYSKNRRS RGAITTGYRFTNFEPFTVNSVNDSLEPV GGLYEIQIPSEFTIGNMVEFIQTSSPKV TIDCAAFVCGDYAACKSQLVEYGSFCDN INAILTEVNELLDTTQLQVANSLMNGVT LSTKLKDGVNFNVDDINFSPVLGCLGSE CSKASSRSAIEDLLFDKVKLSDVGFVEA YNNCTGGAEIRDLICVQSYKGIKVLPPL LSENQISGYTLAATSASLFPPWTAAAGV PFYLNVQYRINGLGVTMDVLSQNQKLIA NAFNNALYAIQEGFDATNSALVKIQAVV NANAEALNNLLQQLSNRFGAISASLQEI LSRLDALEAEAQIDRLINGRLTALNAYV SQQLSDSTLVKFSAAQAMEKVNECVKSQ SSRINFCGNGNHIISLVQNAPYGLYFIH FSYVPTKYVTARVSPGLCIAGDRGIAPK SGYFVNVNNTWMYTGSGYYYPEPITENN VVVMSTCAVNYTKAPYVMLNTSIPNLPD FKEELDQWFKNQTSVAPDLSLDYINVTF LDLQVEMNRLQEAIKVLNQSYINLKDIG TYEYYVKWPWYVWLLICLAGVAMLVLLF FICCCTGCGTSCFKKCGGCCDDYTGYQE LVIKTSHDD |
Protein Length (aa) | 1353 |

EMPS-WCPV-S-1
Epitope Mapping Peptide Set SARS-CoV-2 (Spike Glycoprotein)
Set of 52 Matrix Pools and 315 individual overlapping peptides spanning the whole Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for epitope identification and mapping.
Set of 52 Matrix Pools and 315 individual overlapping peptides spanning the whole Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for epitope identification and mapping.

Epitope Mapping Peptide Set SARS-CoV-2 (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 315 |
Further Information:
Amount | 52 Matrix pools and 315 individual peptide aliquots (5 µg each) |
Specifications | Peptide scan (optimized scan into 15 mers) |
Documentation | Protocol, Datasheet and Annotations |
Swiss-Prot ID | |
Sequence |
MFVFLVLLPLVSSQCVNLTTRTQLPPAY TNSFTRGVYYPDKVFRSSVLHSTQDLFL PFFSNVTWFHAIHVSGTNGTKRFDNPVL PFNDGVYFASTEKSNIIRGWIFGTTLDS KTQSLLIVNNATNVVIKVCEFQFCNDPF LGVYYHKNNKSWMESEFRVYSSANNCTF EYVSQPFLMDLEGKQGNFKNLREFVFKN IDGYFKIYSKHTPINLVRDLPQGFSALE PLVDLPIGINITRFQTLLALHRSYLTPG DSSSGWTAGAAAYYVGYLQPRTFLLKYN ENGTITDAVDCALDPLSETKCTLKSFTV EKGIYQTSNFRVQPTESIVRFPNITNLC PFGEVFNATRFASVYAWNRKRISNCVAD YSVLYNSASFSTFKCYGVSPTKLNDLCF TNVYADSFVIRGDEVRQIAPGQTGKIAD YNYKLPDDFTGCVIAWNSNNLDSKVGGN YNYLYRLFRKSNLKPFERDISTEIYQAG STPCNGVEGFNCYFPLQSYGFQPTNGVG YQPYRVVVLSFELLHAPATVCGPKKSTN LVKNKCVNFNFNGLTGTGVLTESNKKFL PFQQFGRDIADTTDAVRDPQTLEILDIT PCSFGGVSVITPGTNTSNQVAVLYQDVN CTEVPVAIHADQLTPTWRVYSTGSNVFQ TRAGCLIGAEHVNNSYECDIPIGAGICA SYQTQTNSPRRARSVASQSIIAYTMSLG AENSVAYSNNSIAIPTNFTISVTTEILP VSMTKTSVDCTMYICGDSTECSNLLLQY GSFCTQLNRALTGIAVEQDKNTQEVFAQ VKQIYKTPPIKDFGGFNFSQILPDPSKP SKRSFIEDLLFNKVTLADAGFIKQYGDC LGDIAARDLICAQKFNGLTVLPPLLTDE MIAQYTSALLAGTITSGWTFGAGAALQI PFAMQMAYRFNGIGVTQNVLYENQKLIA NQFNSAIGKIQDSLSSTASALGKLQDVV NQNAQALNTLVKQLSSNFGAISSVLNDI LSRLDKVEAEVQIDRLITGRLQSLQTYV TQQLIRAAEIRASANLAATKMSECVLGQ SKRVDFCGKGYHLMSFPQSAPHGVVFLH VTYVPAQEKNFTTAPAICHDGKAHFPRE GVFVSNGTHWFVTQRNFYEPQIITTDNT FVSGNCDVVIGIVNNTVYDPLQPELDSF KEELDKYFKNHTSPDVDLGDISGINASV VNIQKEIDRLNEVAKNLNESLIDLQELG KYEQYIKWPWYIWLGFIAGLIAIVMVTI MLCCMTSCCSCLKGCCSCGSCCKFDEDD SEPVLKGVKLHYT |
Protein Length (aa) | 1273 |

PM-HKU1-S
PepMix™ HCoV- HKU1 (Spike Glycoprotein)
Pool of 327 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus HKU1 (HCoV-HKU1) (isolate N1) for T cell assays (e.g. ELISPOT)
Pool of 327 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus HKU1 (HCoV-HKU1) (isolate N1) for T cell assays (e.g. ELISPOT)

PepMix™ HCoV- HKU1 (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | Human coronavirus (HCoV) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 169+168 |
Further Information:
Amount | 1 vial per subpool containing containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence |
MLLIIFILPTTLAVIGDFNCTNFAINDL NTTVPRISEYVVDVSYGLGTYYILDRVY LNTTILFTGYFPKSGANFRDLSLKGTTY LSTLWYQKPFLSDFNNGIFSRVKNTKLY VNKTLYSEFSTIVIGSVFINNSYTIVVQ PHNGVLEITACQYTMCEYPHTICKSKGS SRNESWHFDKSEPLCLFKKNFTYNVSTD WLYFHFYQERGTFYAYYADSGMPTTFLF SLYLGTLLSHYYVLPLTCNAISSNTDNE TLQYWVTPLSKRQYLLKFDNRGVITNAV DCSSSFFSEIQCKTKSLLPNTGVYDLSG FTVKPVATVHRRIPDLPDCDIDKWLNNF NVPSPLNWERKIFSNCNFNLSTLLRLVH TDSFSCNNFDESKIYGSCFKSIVLDKFA IPNSRRSDLQLGSSGFLQSSNYKIDTTS SSCQLYYSLPAINVTINNYNPSSWNRRY GFNNFNLSSHSVVYSRYCFSVNNTFCPC AKPSFASSCKSHKPPSASCPIGTNYRSC ESTTVLDHTDWCRCSCLPDPITAYDPRS CSQKKSLVGVGEHCAGFGVDEEKCGVLD GSYNVSCLCSTDAFLGWSYDTCVSNNRC NIFSNFILNGINSGTTCSNDLLQPNTEV FTDVCVDYDLYGITGQGIFKEVSAVYYN SWQNLLYDSNGNIIGFKDFVTNKTYNIF PCYAGRVSAAFHQNASSLALLYRNLKCS YVLNNISLTTQPYFDSYLGCVFNADNLT DYSVSSCALRMGSGFCVDYNSPSSSSSR RKRRSISASYRFVTFEPFNVSFVNDSIE SVGGLYEIKIPTNFTIVGQEEFIQTNSP KVTIDCSLFVCSNYAACHDLLSEYGTFC DNINSILDEVNGLLDTTQLHVADTLMQG VTLSSNLNTNLHFDVDNINFKSLVGCLG PHCGSSSRSFFEDLLFDKVKLSDVGFVE AYNNCTGGSEIRDLLCVQSFNGIKVLPP ILSESQISGYTTAATVAAMFPPWSAAAG IPFSLNVQYRINGLGVTMDVLNKNQKLI ATAFNNALLSIQNGFSATNSALAKIQSV VNSNAQALNSLLQQLFNKFGAISSSLQE ILSRLDALEAQVQIDRLINGRLTALNAY VSQQLSDISLVKFGAALAMEKVNECVKS QSPRINFCGNGNHILSLVQNAPYGLLFM HFSYKPISFKTVLVSPGLCISGDVGIAP KQGYFIKHNDHWMFTGSSYYYPEPISDK NVVFMNTCSVNFTKAPLVYLNHSVPKLS DFESELSHWFKNQTSIAPNLTLNLHTIN ATFLDLYYEMNLIQESIKSLNNSYINLK DIGTYEMYVKWPWYVWLLISFSFIIFLV LLFFICCCTGCGSACFSKCHNCCDEYGG HHDFVIKTSHDD |
Protein Length (aa) | 1356 |

PM-229E-S
PepMix™ HCoV-229E (Spike Glycoprotein)
Pool of 291 peptides (delivered in two subpools of 146 & 145 peptides) derived from a peptide scan through the entire Spike glycoprotein of Human coronavirus 229E (HCoV-229E) for T cell assays (e.g. ELISPOT)
Pool of 291 peptides (delivered in two subpools of 146 & 145 peptides) derived from a peptide scan through the entire Spike glycoprotein of Human coronavirus 229E (HCoV-229E) for T cell assays (e.g. ELISPOT)

PepMix™ HCoV-229E (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | Human coronavirus (HCoV) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 146+145 |
Further Information:
Amount | 1 vial per subpool containing containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence |
MFVLLVAYALLHIAGCQTTNGLNTSYSV CNGCVGYSENVFAVESGGYIPSDFAFNN WFLLTNTSSVVDGVVRSFQPLLLNCLWS VSGLRFTTGFVYFNGTGRGDCKGFSSDV LSDVIRYNLNFEENLRRGTILFKTSYGV VVFYCTNNTLVSGDAHIPFGTVLGNFYC FVNTTIGNETTSAFVGALPKTVREFVIS RTGHFYINGYRYFTLGNVEAVNFNVTTA ETTDFCTVALASYADVLVNVSQTSIANI IYCNSVINRLRCDQLSFDVPDGFYSTSP IQSVELPVSIVSLPVYHKHTFIVLYVDF KPQSGGGKCFNCYPAGVNITLANFNETK GPLCVDTSHFTTKYVAVYANVGRWSASI NTGNCPFSFGKVNNFVKFGSVCFSLKDI PGGCAMPIVANWAYSKYYTIGSLYVSWS DGDGITGVPQPVEGVSSFMNVTLDKCTK YNIYDVSGVGVIRVSNDTFLNGITYTST SGNLLGFKDVTKGTIYSITPCNPPDQLV VYQQAVVGAMLSENFTSYGFSNVVELPK FFYASNGTYNCTDAVLTYSSFGVCADGS IIAVQPRNVSYDSVSAIVTANLSIPSNW TTSVQVEYLQITSTPIVVDCSTYVCNGN VRCVELLKQYTSACKTIEDALRNSARLE SADVSEMLTFDKKAFTLANVSSFGDYNL SSVIPSLPTSGSRVAGRSAIEDILFSKL VTSGLGTVDADYKKCTKGLSIADLACAQ YYNGIMVLPGVADAERMAMYTGSLIGGI ALGGLTSAVSIPFSLAIQARLNYVALQT DVLQENQKILAASFNKAMTNIVDAFTGV NDAITQTSQALQTVATALNKIQDVVNQQ GNSLNHLTSQLRQNFQAISSSIQAIYDR LDTIQADQQVDRLITGRLAALNVFVSHT LTKYTEVRASRQLAQQKVNECVKSQSKR YGFCGNGTHIFSIVNAAPEGLVFLHTVL LPTQYKDVEAWSGLCVDGTNGYVLRQPN LALYKEGNYYRITSRIMFEPRIPTMADF VQIENCNVTFVNISRSELQTIVPEYIDV NKTLQELSYKLPNYTVPDLVVEQYNQTI LNLTSEISTLENKSAELNYTVQKLQTLI DNINSTLVDLKWLNRVETYIKWPWWVWL CISVVLIFVVSMLLLCCCSTGCCGFFSC FASSIRGCCESTKLPYYDVEKIHIQ |
Protein Length (aa) | 1173 |

PM-NL63-S-1
PepMix™ HCoV-NL63 (Spike Glycoprotein)
Pool of 337 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus NL63 (HCoV-NL63) for T cell assays (e.g. ELISPOT)
Pool of 337 peptides (delivered in two subpools of 169 & 168 peptides) derived from a peptide scan through Spike glycoprotein of Human coronavirus NL63 (HCoV-NL63) for T cell assays (e.g. ELISPOT)

PepMix™ HCoV-NL63 (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | Human coronavirus (HCoV) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 169+168 |
Further Information:
Amount | 1 vial per subpool containing containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence |
MKLFLILLVLPLASCFFTCNSNANLSML QLGVPDNSSTIVTGLLPTHWFCANQSTS VYSANGFFYIDVGNHRSAFALHTGYYDA NQYYIYVTNEIGLNASVTLKICKFSRNT TFDFLSNASSSFDCIVNLLFTEQLGAPL GITISGETVRLHLYNVTRTFYVPAAYKL TKLSVKCYFNYSCVFSVVNATVTVNVTT HNGRVVNYTVCDDCNGYTDNIFSVQQDG RIPNGFPFNNWFLLTNGSTLVDGVSRLY QPLRLTCLWPVPGLKSSTGFVYFNATGS DVNCNGYQHNSVVDVMRYNLNFSANSLD NLKSGVIVFKTLQYDVLFYCSNSSSGVL DTTIPFGPSSQPYYCFINSTINTTHVST FVGILPPTVREIVVARTGQFYINGFKYF DLGFIEAVNFNVTTASATDFWTVAFATF VDVLVNVSATNIQNLLYCDSPFEKLQCE HLQFGLQDGFYSANFLDDNVLPETYVAL PIYYQHTDINFTATASFGGSCYVCKPHQ VNISLNGNTSVCVRTSHFSIRYIYNRVK SGSPGDSSWHIYLKSGTCPFSFSKLNNF QKFKTICFSTVEVPGSCNFPLEATWHYT SYTIVGALYVTWSEGNSITGVPYPVSGI REFSNLVLNNCTKYNIYDYVGTGIIRSS NQSLAGGITYVSNSGNLLGFKNVSTGNI FIVTPCNQPDQVAVYQQSIIGAMTAVNE SRYGLQNLLQLPNFYYVSNGGNNCTTAV MTYSNFGICADGSLIPVRPRNSSDNGIS AIITANLSIPSNWTTSVQVEYLQITSTP IVVDCATYVCNGNPRCKNLLKQYTSACK TIEDALRLSAHLETNDVSSMLTFDSNAF SLANVTSFGDYNLSSVLPQRNIRSSRIA GRSALEDLLFSKVVTSGLGTVDVDYKSC TKGLSIADLACAQYYNGIMVLPGVADAE RMAMYTGSLIGGMVLGGLTSAAAIPFSL ALQARLNYVALQTDVLQENQKILAASFN KAINNIVASFSSVNDAITQTAEAIHTVT IALNKIQDVVNQQGSALNHLTSQLRHNF QAISNSIQAIYDRLDSIQADQQVDRLIT GRLAALNAFVSQVLNKYTEVRGSRRLAQ QKINECVKSQSNRYGFCGNGTHIFSIVN SAPDGLLFLHTVLLPTDYKNVKAWSGIC VDGIYGYVLRQPNLVLYSDNGVFRVTSR VMFQPRLPVLSDFVQIYNCNVTFVNISR VELHTVIPDYVDVNKTLQEFAQNLPKYV KPNFDLTPFNLTYLNLSSELKQLEAKTA SLFQTTVELQGLIDQINSTYVDLKLLNR FENYIKWPWWVWLIISVVFVVLLSLLVF CCLSTGCCGCCNCLTSSMRGCCDCGSTK LPYYEFEKVHVQ |
Protein Length (aa) | 1356 |

PM-OC43-S
PepMix™ HCoV-OC43 (Spike Glycoprotein)
Pool of 336 peptides (delivered in two subpools of 168 peptides each) derived from a peptide scan through the entire Spike glycoprotein of Human coronavirus OC43 (HCoV-OC43) for T cell assays (e.g. ELISPOT)
Pool of 336 peptides (delivered in two subpools of 168 peptides each) derived from a peptide scan through the entire Spike glycoprotein of Human coronavirus OC43 (HCoV-OC43) for T cell assays (e.g. ELISPOT)

PepMix™ HCoV-OC43 (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | Human coronavirus (HCoV) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 168+168 |
Further Information:
Amount | 1 vial per subpool containing containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence |
MFLILLISLPTAFAVIGDLKCTSDNIND KDTGPPPISTDTVDVTNGLGTYYVLDRV YLNTTLFLNGYYPTSGSTYRNMALKGSV LLSRLWFKPPFLSDFINGIFAKVKNTKV IKDRVMYSEFPAITIGSTFVNTSYSVVV QPRTINSTQDGDNKLQGLLEVSVCQYNM CEYPQTICHPNLGNHRKELWHLDTGVVS CLYKRNFTYDVNADYLYFHFYQEGGTFY AYFTDTGVVTKFLFNVYLGMALSHYYVM PLTCNSKLTLEYWVTPLTSRQYLLAFNQ DGIIFNAEDCMSDFMSEIKCKTQSIAPP TGVYELNGYTVQPIADVYRRKPNLPNCN IEAWLNDKSVPSPLNWERKTFSNCNFNM SSLMSFIQADSFTCNNIDAAKIYGMCFS SITIDKFAIPNGRKVDLQLGNLGYLQSF NYRIDTTATSCQLYYNLPAANVSVSRFN PSTWNKRFGFIEDSVFKPRPAGVLTNHD VVYAQHCFKAPKNFCPCKLNGSCVGSGP GKNNGIGTCPAGTNYLTCDNLCTPDPIT FTGTYKCPQTKSLVGIGEHCSGLAVKSD YCGGNSCTCRPQAFLGWSADSCLQGDKC NIFANFILHDVNSGLTCSTDLQKANTDI ILGVCVNYDLYGILGQGIFVEVNATYYN SWQNLLYDSNGNLYGFRDYIINRTFMIR SCYSGRVSAAFHANSSEPALLFRNIKCN YVFNNSLTRQLQPINYFDSYLGCVVNAY NSTAISVQTCDLTVGSGYCVDYSKNRRS RGAITTGYRFTNFEPFTVNSVNDSLEPV GGLYEIQIPSEFTIGNMVEFIQTSSPKV TIDCAAFVCGDYAACKSQLVEYGSFCDN INAILTEVNELLDTTQLQVANSLMNGVT LSTKLKDGVNFNVDDINFSPVLGCLGSE CSKASSRSAIEDLLFDKVKLSDVGFVEA YNNCTGGAEIRDLICVQSYKGIKVLPPL LSENQISGYTLAATSASLFPPWTAAAGV PFYLNVQYRINGLGVTMDVLSQNQKLIA NAFNNALYAIQEGFDATNSALVKIQAVV NANAEALNNLLQQLSNRFGAISASLQEI LSRLDALEAEAQIDRLINGRLTALNAYV SQQLSDSTLVKFSAAQAMEKVNECVKSQ SSRINFCGNGNHIISLVQNAPYGLYFIH FSYVPTKYVTARVSPGLCIAGDRGIAPK SGYFVNVNNTWMYTGSGYYYPEPITENN VVVMSTCAVNYTKAPYVMLNTSIPNLPD FKEELDQWFKNQTSVAPDLSLDYINVTF LDLQVEMNRLQEAIKVLNQSYINLKDIG TYEYYVKWPWYVWLLICLAGVAMLVLLF FICCCTGCGTSCFKKCGGCCDDYTGYQE LVIKTSHDD |
Protein Length (aa) | 1353 |

PM-WCPV-S-RBD
PepMix™ SARS-CoV-2 (S-RBD)
Pool of 53 peptides derived from a peptide scan through Receptor Binding Domain of Spike Glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
Pool of 53 peptides derived from a peptide scan through Receptor Binding Domain of Spike Glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)

PepMix™ SARS-CoV-2 (S-RBD)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Receptor Binding Domain of Spike Glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 53 |
Further Information:
Amount | 1 vial containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence |
RVQPTESIVRFPNITNLCPFGEVFNATR FASVYAWNRKRISNCVADYSVLYNSASF STFKCYGVSPTKLNDLCFTNVYADSFVI RGDEVRQIAPGQTGKIADYNYKLPDDFT GCVIAWNSNNLDSKVGGNYNYLYRLFRK SNLKPFERDISTEIYQAGSTPCNGVEGF NCYFPLQSYGFQPTNGVGYQPYRVVVLS FELLHAPATVCGPKKSTNLVKNKCVNF |
Protein Length (aa) | 223 |

PM-SARS2-S-MUT-1
PepMix™ SARS-CoV-2 (Spike D614G)
Pool of 4 peptides derived from a peptide scan through the region around mutation D614G of Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
Pool of 4 peptides derived from a peptide scan through the region around mutation D614G of Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)

PepMix™ SARS-CoV-2 (Spike D614G)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 4 |
Further Information:
Amount | 1 vial containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence | see Datasheet |
Protein Length (aa) | 27 |

PM-WCPV-S
PepMix™ SARS-CoV-2 (Spike Glycoprotein)
Pool of 315 peptides (delivered in two subpools of 158 & 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)
Pool of 315 peptides (delivered in two subpools of 158 & 157 peptides) derived from a peptide scan through the entire Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) for T cell assays (e.g. ELISPOT)

PepMix™ SARS-CoV-2 (Spike Glycoprotein)

Application |
Antigen specific T-cell stimulation Immune monitoring T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 158+157 |
Further Information:
Amount | 1 vial per subpool containing containing 15 nmol (appr. 25µg) per peptide for stimulation of 2,5 x 108 cells |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol and Datasheet |
Swiss-Prot ID | |
Sequence |
MFVFLVLLPLVSSQCVNLTTRTQLPPAY TNSFTRGVYYPDKVFRSSVLHSTQDLFL PFFSNVTWFHAIHVSGTNGTKRFDNPVL PFNDGVYFASTEKSNIIRGWIFGTTLDS KTQSLLIVNNATNVVIKVCEFQFCNDPF LGVYYHKNNKSWMESEFRVYSSANNCTF EYVSQPFLMDLEGKQGNFKNLREFVFKN IDGYFKIYSKHTPINLVRDLPQGFSALE PLVDLPIGINITRFQTLLALHRSYLTPG DSSSGWTAGAAAYYVGYLQPRTFLLKYN ENGTITDAVDCALDPLSETKCTLKSFTV EKGIYQTSNFRVQPTESIVRFPNITNLC PFGEVFNATRFASVYAWNRKRISNCVAD YSVLYNSASFSTFKCYGVSPTKLNDLCF TNVYADSFVIRGDEVRQIAPGQTGKIAD YNYKLPDDFTGCVIAWNSNNLDSKVGGN YNYLYRLFRKSNLKPFERDISTEIYQAG STPCNGVEGFNCYFPLQSYGFQPTNGVG YQPYRVVVLSFELLHAPATVCGPKKSTN LVKNKCVNFNFNGLTGTGVLTESNKKFL PFQQFGRDIADTTDAVRDPQTLEILDIT PCSFGGVSVITPGTNTSNQVAVLYQDVN CTEVPVAIHADQLTPTWRVYSTGSNVFQ TRAGCLIGAEHVNNSYECDIPIGAGICA SYQTQTNSPRRARSVASQSIIAYTMSLG AENSVAYSNNSIAIPTNFTISVTTEILP VSMTKTSVDCTMYICGDSTECSNLLLQY GSFCTQLNRALTGIAVEQDKNTQEVFAQ VKQIYKTPPIKDFGGFNFSQILPDPSKP SKRSFIEDLLFNKVTLADAGFIKQYGDC LGDIAARDLICAQKFNGLTVLPPLLTDE MIAQYTSALLAGTITSGWTFGAGAALQI PFAMQMAYRFNGIGVTQNVLYENQKLIA NQFNSAIGKIQDSLSSTASALGKLQDVV NQNAQALNTLVKQLSSNFGAISSVLNDI LSRLDKVEAEVQIDRLITGRLQSLQTYV TQQLIRAAEIRASANLAATKMSECVLGQ SKRVDFCGKGYHLMSFPQSAPHGVVFLH VTYVPAQEKNFTTAPAICHDGKAHFPRE GVFVSNGTHWFVTQRNFYEPQIITTDNT FVSGNCDVVIGIVNNTVYDPLQPELDSF KEELDKYFKNHTSPDVDLGDISGINASV VNIQKEIDRLNEVAKNLNESLIDLQELG KYEQYIKWPWYIWLGFIAGLIAIVMVTI MLCCMTSCCSCLKGCCSCGSCCKFDEDD SEPVLKGVKLHYT |
Protein Length (aa) | 1273 |

Antigen Peptides
SP-WCPV-047
SARS-CoV-2 Antigen Peptide SPIKE (AGCLIGAEHVNNSYECDI)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (AGCLIGAEHVNNSYECDI)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-025
SARS-CoV-2 Antigen Peptide SPIKE (ALNTLVKQL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (ALNTLVKQL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-040
SARS-CoV-2 Antigen Peptide SPIKE (AQKFNGLTVLPPLLTDEM)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (AQKFNGLTVLPPLLTDEM)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-021
SARS-CoV-2 Antigen Peptide SPIKE (FIAGLIAIV)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (FIAGLIAIV)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-022
SARS-CoV-2 Antigen Peptide SPIKE (GAALQIPFAMQMAYRF)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (GAALQIPFAMQMAYRF)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-037
SARS-CoV-2 Antigen Peptide SPIKE (KLPDDFTGCV)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (KLPDDFTGCV)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-027
SARS-CoV-2 Antigen Peptide SPIKE (LITGRLQSL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (LITGRLQSL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-023
SARS-CoV-2 Antigen Peptide SPIKE (MAYRFNGIGVTQNVLY)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (MAYRFNGIGVTQNVLY)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-020
SARS-CoV-2 Antigen Peptide SPIKE (NLNESLIDL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (NLNESLIDL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-024
SARS-CoV-2 Antigen Peptide SPIKE (QALNTLVKQLSSNFGAI)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (QALNTLVKQLSSNFGAI)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-017
SARS-CoV-2 Antigen Peptide SPIKE (QLIRAAEIRASANLAATK)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (QLIRAAEIRASANLAATK)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-019
SARS-CoV-2 Antigen Peptide SPIKE (RLNEVAKNL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (RLNEVAKNL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-038
SARS-CoV-2 Antigen Peptide SPIKE (SIIAYTMSL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (SIIAYTMSL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-039
SARS-CoV-2 Antigen Peptide SPIKE (TECSNLLLQYGSFCTQL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (TECSNLLLQYGSFCTQL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-026
SARS-CoV-2 Antigen Peptide SPIKE (VLNDILSRL)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (VLNDILSRL)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

SP-WCPV-018
SARS-CoV-2 Antigen Peptide SPIKE (VVFLHVTYV)
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.
Antigen Peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxity or proliferation assays.

SARS-CoV-2 Antigen Peptide SPIKE (VVFLHVTYV)

Application |
Antigen specific T-cell stimulation T-cell assays T-cell expansion |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 1 |
Further Information:
Amount | 1 vial containing 50 µg peptide |
Specifications | Peptide as TFA salt |
Documentation | Product Datasheet |
Swiss-Prot ID |

RepliTope™ Peptide Microarrays
RT-MW-WCPV-Spike
Multiwell RepliTope™ SARS-COV-2 (Spike Glycoprotein)
Peptide microarray displaying 315 peptides derived from a peptide scan through the whole Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2). Incubation with 6 samples (and one control) in parallel using the Array Sl
Peptide microarray displaying 315 peptides derived from a peptide scan through the whole Spike glycoprotein of SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2). Incubation with 6 samples (and one control) in parallel using the Array Sl

Multiwell RepliTope™ SARS-COV-2 (Spike Glycoprotein)

Application |
Antibody epitope discovery Immune monitoring |
Protein Name | Spike glycoprotein |
Organism | SARS-CoV-2 (Severe Acute Respiratory Syndrome-related coronavirus 2) |
Indication / Topic |
Covid-19 Infection Respiratory infection |
Number of peptides | 315 |
Further Information:
Amount | 1 peptide microarray (each peptide is deposited 3x per subarray, 3x7 subarrays per slide) |
Specifications | Peptide scan (15mers with 11 aa overlap) |
Documentation | Protocol, Datasheet, gal-file and gal-viewer |
Swiss-Prot ID | |
Sequence |
MFVFLVLLPLVSSQCVNLTTRTQLPPAY TNSFTRGVYYPDKVFRSSVLHSTQDLFL PFFSNVTWFHAIHVSGTNGTKRFDNPVL PFNDGVYFASTEKSNIIRGWIFGTTLDS KTQSLLIVNNATNVVIKVCEFQFCNDPF LGVYYHKNNKSWMESEFRVYSSANNCTF EYVSQPFLMDLEGKQGNFKNLREFVFKN IDGYFKIYSKHTPINLVRDLPQGFSALE PLVDLPIGINITRFQTLLALHRSYLTPG DSSSGWTAGAAAYYVGYLQPRTFLLKYN ENGTITDAVDCALDPLSETKCTLKSFTV EKGIYQTSNFRVQPTESIVRFPNITNLC PFGEVFNATRFASVYAWNRKRISNCVAD YSVLYNSASFSTFKCYGVSPTKLNDLCF TNVYADSFVIRGDEVRQIAPGQTGKIAD YNYKLPDDFTGCVIAWNSNNLDSKVGGN YNYLYRLFRKSNLKPFERDISTEIYQAG STPCNGVEGFNCYFPLQSYGFQPTNGVG YQPYRVVVLSFELLHAPATVCGPKKSTN LVKNKCVNFNFNGLTGTGVLTESNKKFL PFQQFGRDIADTTDAVRDPQTLEILDIT PCSFGGVSVITPGTNTSNQVAVLYQDVN CTEVPVAIHADQLTPTWRVYSTGSNVFQ TRAGCLIGAEHVNNSYECDIPIGAGICA SYQTQTNSPRRARSVASQSIIAYTMSLG AENSVAYSNNSIAIPTNFTISVTTEILP VSMTKTSVDCTMYICGDSTECSNLLLQY GSFCTQLNRALTGIAVEQDKNTQEVFAQ VKQIYKTPPIKDFGGFNFSQILPDPSKP SKRSFIEDLLFNKVTLADAGFIKQYGDC LGDIAARDLICAQKFNGLTVLPPLLTDE MIAQYTSALLAGTITSGWTFGAGAALQI PFAMQMAYRFNGIGVTQNVLYENQKLIA NQFNSAIGKIQDSLSSTASALGKLQDVV NQNAQALNTLVKQLSSNFGAISSVLNDI LSRLDKVEAEVQIDRLITGRLQSLQTYV TQQLIRAAEIRASANLAATKMSECVLGQ SKRVDFCGKGYHLMSFPQSAPHGVVFLH VTYVPAQEKNFTTAPAICHDGKAHFPRE GVFVSNGTHWFVTQRNFYEPQIITTDNT FVSGNCDVVIGIVNNTVYDPLQPELDSF KEELDKYFKNHTSPDVDLGDISGINASV VNIQKEIDRLNEVAKNLNESLIDLQELG KYEQYIKWPWYIWLGFIAGLIAIVMVTI MLCCMTSCCSCLKGCCSCGSCCKFDEDD SEPVLKGVKLHYT |
Protein Length (aa) | 1273 |

News
NEW: SARS-COV-2 B.1.1.7(UK) & HCoV NCAP PepMixesTM
(Jan 2021)
Read more
13 NEW Immunopeptidomics Kits
References for MHC I binding HLA peptides to increase accuracy of neo-epitope identification
(Dec 2020)
Read more
Infectious diseases beyond COVID-19
JPT's peptide formats in the literature
(Oct 2020)
Read more
SARS COV-2 Mass Spec Reference Kit Released!:
SARS-CoV-2 SpikeMix for Mass Spectrometry covers spike, NCAP, VME-1 & ORF9B
(July 2020)
Read more
Quality Assurance
All production is performed according to ISO 9001:2015 standards.